Literature DB >> 10894974

Topical colchicine therapy for actinic keratoses.

M Grimaître1, A Etienne, M Fathi, P A Piletta, J H Saurat.   

Abstract

BACKGROUND: The beneficial effect of topical colchicine therapy for actinic keratoses has already been described in 1968.
OBJECTIVE: To confirm that the application of a 1% colchicine gel is a safe and effective treatment for actinic keratoses.
METHODS: Twenty patients were included in a double-blinded protocol. They all had actinic keratoses on the scalp, most of which had been previously treated with 5-fluorouracil or cryotherapy. Ten patients applied twice daily on the forehead a hydrophilic gel (placebo group), while the other 10 where treated with the same gel containing 1% of colchicine (colchicine group). Erythema and efficacy were evaluated at each control on days 7, 30 and 60, with repetitive blood tests to exclude a possible systemic absorption.
RESULTS: A complete healing of the solar keratoses was observed in 7 out of the 10 patients treated with 1% colchicine gel; these showed no recurrence after 2 months of follow-up. Burning and itching occurred only in the colchicine group after 2 or 3 days of application, with an inflammatory reaction on the areas where the gel was applied, while pustules and crusts were located specifically on the actinic keratoses. Repeated blood controls showed that there was no systemic absorption.
CONCLUSIONS: This double-blind placebo-controlled study confirms the activity of colchicine for the treatment of actinic keratosis. A comparison with other topical treatments in terms of efficacy and practicability is needed. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894974     DOI: 10.1159/000018407

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  8 in total

Review 1.  Colchicine: an ancient drug with novel applications.

Authors:  B Dasgeb; D Kornreich; K McGuinn; L Okon; I Brownell; D L Sackett
Journal:  Br J Dermatol       Date:  2018-01-03       Impact factor: 9.302

Review 2.  Interventions for actinic keratoses.

Authors:  Aditya K Gupta; Maryse Paquet; Elmer Villanueva; William Brintnell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 3.  Prevention of non-melanoma skin cancer.

Authors:  S P Stratton
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

4.  [Topical therapy of squamous cell carcinoma].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 5.  Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features.

Authors:  Foad Rommasi; Mohammad Javad Nasiri; Mehdi Mirsaeidi
Journal:  Mol Cell Biochem       Date:  2022-01-11       Impact factor: 3.842

Review 6.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

7.  A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate.

Authors:  Robert Rosen; Ellen Marmur; Lawrence Anderson; Peter Welburn; Janelle Katsamas
Journal:  Dermatol Ther (Heidelb)       Date:  2014-07-30

8.  Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study.

Authors:  Gita Faghihi; Azam Elahipoor; Fariba Iraji; Shadi Behfar; Bahareh Abtahi-Naeini
Journal:  Adv Med       Date:  2016-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.